SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Cannabis Suisse Corp. (CSUI) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 13/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — CSUI
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio18.85
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.00 |
$0.00 |
$-1.73K |
- |
| 2017 |
$0.00 |
$14.19K |
$-26.67K |
-187.9% |
| 2018 |
$0.00 |
$6.5K |
$-16.42K |
-252.6% |
| 2019 |
$0.00 |
$7.53K |
$-22.73K |
-301.8% |
| 2020 |
$-0.01 |
$242.74K |
$-389K |
-160.3% |
| 2021 |
$-0.01 |
$50.85K |
$-411K |
-808.3% |
| 2022 |
$-0.01 |
$7.77K |
$-187.89K |
-2418.1% |
| 2023 |
$-0.01 |
$10K |
$-351.55K |
-3515.5% |
| 2024 |
$-0.03 |
$30K |
$-1.27M |
-4216.7% |
| 2025 |
$-0.01 |
$22.5K |
$-456.14K |
-2027.3% |
